• Forest Laboratories Inc., of New York, and Royalty Pharma Collection Trust jointly filed an additional lawsuit in the U.S. District Court for the District of Delaware against First Time US Generics LLC for infringement of patents related to Forest’s Savella (milnacipran HCL).